Navigation Links
Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
Date:1/15/2008

ity Lipoprotein Cholesterol (LDL-C), known as "bad" cholesterol, oxidized LDL, and apolipoprotein-B100 (Apo-B) coupled with equally meaningful reductions of C-Reactive Protein (CRP), a recognized marker of inflammation and possible cardiovascular risk. Decreases in these levels with A-002 treatment were most significant among patients already on a background of statin therapy.

Further information about Anthera's clinical trials can be found at http://www.PLASMAtrial.com or http://www.anthera.com.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a privately-held company committed to developing and commercializing clinical pharmaceutical products that address unmet medical needs of patients with life-threatening, chronic and acute inflammatory diseases. The Company has acquired from Eli Lilly and Company and Shionogi & Co. Ltd. worldwide rights (excluding Japan) to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase A2 (PLA2) family -- a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes prostacyclins and other mediators of inflammation. These highly potent compounds inhibit novel upstream steps in the inflammation cascade and have the potential to address a variety of diseases. For more information, please visit http://www.anthera.com.

Contact:

Anne Bowdidge

(650) 218-6900

pr@anthera.com


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 PuraMed BioScience ® ... of over-the-counter (OTC) medicinal and healthcare products, announced ... M name along with the name,s red and ... the trademarked name MigraPure ®  going forward. ... PuraMed,s homeopathic, natural migraine pain reliever will be ...
(Date:7/30/2014)... 30, 2014  Today the US Surgeon General issued the ... tanning or sun burns stating they can lead directly to ... Boris Lushniak , says that "skin cancer is a major ... much exposure to indoor and outdoor ultraviolet light is a ... Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... July 30, 2014  El Camino Hospital, a leader ... is utilizing the Leaf Patient Monitoring system to help ... movement of patients susceptible to bed sores. ... 138-patient study of the system, which showed dramatic improvement ... patients regularly is the one of the most effect ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3
... Conn., March 30, 2011 Attendees of the 60th ... New Orleans, La., can see first hand the benefits ... Available for sale in the U.S., Synapse 3D is ... directly into Synapse® Cardiovascular, Fujifilm,s CVIS / C-PACS. During ...
... PORT WASHINGTON, N.Y., March 30, 2011 Premier Heart, LLC ... 11, the 60th Annual Scientific Sessions and Expo of the ... in New Orleans. The MCG offers completely non-invasive cardiac testing ... diagnosis" according to its latest US FDA 510K Clearance.  MCG ...
Cached Medicine Technology:Fujifilm Highlights Synapse® 3D at ACC 2Fujifilm Highlights Synapse® 3D at ACC 3Premier Heart to Exhibit its Multifunction CardioGram (MCG™) at American College of Cardiology in New Orleans April 2-5 2
(Date:7/30/2014)... can happen in an instant: A small child pulls up ... critically injured when the furniture tips over. "Every parent ... homes and imagine what could tip over, fall off walls ... becoming a reality," Dr. Alex Rosenau, president of the American ... Between 2009 and 2011, roughly 43,000 people ended up ...
(Date:7/30/2014)... New York (PRWEB) July 30, 2014 ... uncontrollable brain bleeding has filed a Xarelto lawsuit ( ... the blood thinner, Bernstein Liebhard LLP reports. According to ... for the District of Vermont on July 25th, the ... when he suffered an irreversible brain bleed that ultimately ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Some obese people ... the reward centers in their brains when they see ... how this mutation triggers feelings of pleasure and gratification ... help improve strategies designed to prevent overeating, the scientists ... obese. Obesity is typically caused by a combination ...
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed people with diverticulitis and confirmed that many suffer psychological and physical symptoms long after their acute illness ... led by Dr. Brennan Spiegel interviewed patients in great detail about the symptoms they experience weeks, months or even years after an ...
(Date:7/30/2014)... 2014 LTC Consumer, an independent, free online ... insurance, features an Instant Quote tool on its website, ... LTC Consumer. Quotes are free and unlimited. , The ... seven areas – including age, gender, and state of residence ... (you don’t need to enter any contact information to get ...
Breaking Medicine News(10 mins):Health News:Tip-Over Furniture Can Kill Kids 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Gene Mutation May Make Food More Tempting 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2
... By Kathleen Doheny HealthDay Reporter , TUESDAY, ... two strains of human papillomavirus (HPV) that are most likely ... with the Pap test, may be more accurate for many ... And, for those women who are HPV-positive, using the ...
... surrounding the Food and Drug Administration,s ruling that Avastin ... cancer, a new multinational Phase III clinical trial shows ... cancer patients when given before surgery. At ... Oncology, the nation,s premier association of clinical oncologists, Harry ...
... treated at a U.S. military hospital in Afghanistan often ... the September issue of Infection Control and Hospital ... Epidemiology of America. The findings underscore the need for ... soldiers and local patients are treated, the study,s authors ...
... Toronto,s psychology department show that people who use ... surgery are viewed more negatively than those who use ... younger adults are more negative about using anti-aging methods ... the rapid growth of the anti-aging cosmetic industry, age ...
... HealthDay Reporter , TUESDAY, Aug. 23 ... (ADHD) have a much higher risk of developing a ... ADHD experts, the current observation does not come as ... children with ADHD stand a much higher chance of ...
... responsible for cells of different tissues of our body to ... matching receptors on the surface of their target cells and ... single genetic alteration can be sufficient for the whole system ... for such a growth factor or for the matching receptor ...
Cached Medicine News:Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 2Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 3Health News:Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients 2Health News:Study: Afghan patients a common source of drug-resistant bacteria 2Health News:U of T research shows anti-aging techniques not yet viewed as acceptable 2Health News:Study Links Writing Difficulties to ADHD 2Health News:Study Links Writing Difficulties to ADHD 3Health News:Stop signal for leukemia stem cells 2
... Acclaim 7000 Nd:YAG laser allows you ... cosmetic procedures such as hair removal, ... our Dermique LaserFACIAL for sun-damaged skin. ... parameters for customizing treatment based on ...
... full system for hair removal, with scanner and ... hair reduction system. The 90W laser generates ... hair bulb and bugle. To ease and optimise ... tissue through the MedArt® 413 scanner.,The laser beam ...
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
Medicine Products: